Company Profiles

driven by the PitchBook Platform

Birich Technologies

2011 FOUNDED
PRIVATE STATUS
Seed LATEST DEAL TYPE
$151K LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of gene-silencing technology. The company offers a proprietary protein delivery technology for RNAI.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Primary Office
301 West Preston Street
Room 801
Baltimore, MD 21201
United States

+1 (301) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Birich Technologies’s full profile, request a free trial.

Birich Technologies Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 26-Feb-2014 $151K 00000 Completed Startup
1. Accelerator/Incubator 20-Feb-2013 00000 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Birich Technologies Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Maryland Industrial Partnerships Accelerator/Incubator Minority 000 0000 000000 0

Birich Technologies Executive Team (3)

Name Title Board
Seat
Contact
Info
Vivek Advani Acting Chief Technology Officer
Kevin Diehn Co-Founder & Chief Executive Officer
Chanda Arya Ph.D Co-Founder & President
Questions or concerns about this profile? Reach out to website-support@pitchbook.com